Literature DB >> 23706857

Recipient ineligibility after liver transplantation assessment: a single centre experience.

Aman Arya1, Roberto Hernandez-Alejandro, Paul Marotta, Julia Uhanova, Natasha Chandok.   

Abstract

BACKGROUND: Candidacy for liver transplantation is determined through standardized evaluation. There are limited data on the frequency and reasons for denial of transplantation after assessment; analysis may shed light on the short-term utility of the assessment. We sought to describe the frequency and reasons for ineligibility for liver transplantation among referred adults.
METHODS: We studied all prospectively followed recipient candidates at a single centre who were deemed unsuitable for liver transplantation after assessment. Inclusion criteria were age 18 years and older and completion of a standard liver transplantation evaluation over a 3-year period. Patients were excluded if they had a history of prior assessment or liver transplantation within the study period. Demographic and baseline clinical data and reasons for recipient ineligibility were recorded.
RESULTS: In all, 337 patients underwent their first liver transplantation evaluation during the study period; 166 (49.3%) fulfilled inclusion criteria. The mean age was 55.4 years, and 106 (63.9%) were men. The 3 most common reasons for denial of listing were patient too well (n = 82, 49.4%), medical comorbidities and/or need for medical optimization (n = 43, 25.9%) and need for addiction rehabilitation (n = 28, 16.9%).
CONCLUSION: Ineligibility for transplantation after assessment was common, occurring in nearly half of the cohort. Most denied candidates could be identified with more discriminate screening before the resource-intensive assessment; however, the assessment likely provides unforeseen positive impacts on patient care.

Entities:  

Mesh:

Year:  2013        PMID: 23706857      PMCID: PMC3672443          DOI: 10.1503/cjs.004512

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  15 in total

1.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

Review 2.  Hepatitis C: epidemiology, diagnosis, natural history and therapy.

Authors:  Stanislas Pol; Anaïs Vallet-Pichard; Marion Corouge; Vincent O Mallet
Journal:  Contrib Nephrol       Date:  2012-01-30       Impact factor: 1.580

3.  Adult liver transplant survey: policies towards eligibility criteria in Canada and the United States 2007.

Authors:  Karen I Kroeker; Vincent G Bain; Thomas Shaw-Stiffel; Tse-Ling Fong; Eric M Yoshida
Journal:  Liver Int       Date:  2008-11       Impact factor: 5.828

4.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

Authors:  Michael R Charlton; Justin M Burns; Rachel A Pedersen; Kymberly D Watt; Julie K Heimbach; Ross A Dierkhising
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

Review 5.  Liver transplantation. American Association for the Study of Liver Diseases.

Authors:  R L Carithers
Journal:  Liver Transpl       Date:  2000-01       Impact factor: 5.799

Review 6.  Epidemiology of hepatocellular carcinoma.

Authors:  H B el-Serag
Journal:  Clin Liver Dis       Date:  2001-02       Impact factor: 6.126

7.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

Authors:  Vincenzo Mazzaferro; Josep M Llovet; Rosalba Miceli; Sherrie Bhoori; Marcello Schiavo; Luigi Mariani; Tiziana Camerini; Sasan Roayaie; Myron E Schwartz; Gian Luca Grazi; René Adam; Peter Neuhaus; Mauro Salizzoni; Jordi Bruix; Alejandro Forner; Luciano De Carlis; Umberto Cillo; Andrew K Burroughs; Roberto Troisi; Massimo Rossi; Giorgio E Gerunda; Jan Lerut; Jacques Belghiti; Ilka Boin; Jean Gugenheim; Fedja Rochling; Bart Van Hoek; Pietro Majno
Journal:  Lancet Oncol       Date:  2008-12-04       Impact factor: 41.316

8.  Selection of patients for liver transplantation and allocation of donated livers in the UK.

Authors:  J Neuberger; A Gimson; M Davies; M Akyol; J O'Grady; A Burroughs; M Hudson
Journal:  Gut       Date:  2007-09-25       Impact factor: 23.059

9.  Influence of local provision of specialty health care service on patient access to care.

Authors:  Vivian C McAlister
Journal:  Can J Surg       Date:  2007-04       Impact factor: 2.089

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  5 in total

1.  Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.

Authors:  V Martel-Laferrière; A Michel; S Schaefer; S Bindal; K Bichoupan; A D Branch; S Huprikar; T D Schiano; P V Perumalswami
Journal:  Transpl Infect Dis       Date:  2015-06-15       Impact factor: 2.228

2.  Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.

Authors:  Andreas Zori; Faith Villanueva; Diana Hatamleh; Media Ismael; Justin Forde; Manoela Mota; Lindsey Johnson; Roniel Cabrera
Journal:  Dig Dis Sci       Date:  2020-03-26       Impact factor: 3.199

3.  Barriers for Liver Transplant in Patients with Alcohol-Related Hepatitis.

Authors:  Gina Choi; Jihane N Benhammou; Jung J Yum; Elena G Saab; Ankur P Patel; Andrew J Baird; Stephanie Aguirre; Douglas G Farmer; Sammy Saab
Journal:  J Clin Exp Hepatol       Date:  2021-09-22

4.  Being accompanied to liver discharge clinic: An easy measure to identify potential liver transplant candidates among those previously considered ineligible.

Authors:  Jordan Sack; Nilofar Najafian; Angela DeLisle; Simona Jakab
Journal:  World J Hepatol       Date:  2019-04-27

5.  Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease.

Authors:  Scott Coppel; Karan Mathur; Burcin Ekser; Kavish R Patidar; Eric Orman; Archita P Desai; Eduardo Vilar-Gomez; Chandrashekhar Kubal; Naga Chalasani; Lauren Nephew; Marwan Ghabril
Journal:  BMC Gastroenterol       Date:  2020-09-16       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.